A
TNDM icon

Astrantus’s Tandem Diabetes Care TNDM Stock Holding History

Astrantus’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$222K Buy
+1,911
New +$223K 0.37% 159

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Astrantus's TNDM Position: Q1 2022 in Review

Astrantus opened a new position in Tandem Diabetes Care (TNDM) in Q1 2022: 1,911 shares worth $222K. The stake represents 0.37% of the portfolio and ranks #159 among its holdings.

379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Astrantus held 1,911 shares of Tandem Diabetes Care worth $222K as of Q1 2022.
  • Tandem Diabetes Care was a new Astrantus position in Q1 2022.
  • Tandem Diabetes Care made up 0.37% of Astrantus's portfolio in Q1 2022, its #159 holding.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.